References
- Buysse, D. (2013). Insomnia. Journal of the American Medical Association, 309(7), 706–716. doi:10.1001/jama.2013.193
- Center for Medicare and Medicaid Services (2013). Center for clinical standards and quality/survey & certification group memorandum on the CMS national partnership to improve dementia care in nursing homes. Retrieved from https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-13-35.pdf
- Clark, T. (2012). The role of medications in the lives of older adults: An overview. Journal of the American Society on Aging, 35(4), 6–11.
- Harris-Kojetin, L., Sengupta, M., & Park-Lee, E. (2016). Long-term care providers and services users in the United States: Data from the national study of long-term care providers. National Center for Health Statistics, 3(38), 1–118.
- Hefner, G., Stieffenhofer, V., Gabriel, S., Palmer, G., Muller, K., Roschke, J., & Hiemke, C. (2015). Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy. European Journal of Clinical Pharmacology, 71, 165–172. doi:10.1007/s00228-014-1796-5
- Jamsen, K., Ilomaki, J., Hilmer, S., Jokanovic, N., Tan, E., & Bell, S. (2016). A systematic review of the statistical methods in prospective cohort studies investigating the effect of medications on cognition in older people. Research in Social and Administrative Pharmacy, 12, 20–28. doi:10.1016/j.sapharm.2015.04.004
- Kosevich, G., Leinfelder, A., Sandin, K., Swift, E., Taber, S., Weber, R., & Finkelstein, M. (2014). Nurse practitioners in medical rehabilitation settings: A description of practice roles and patterns. Journal of the American Association of Nurse Practitioners, 26(4), 194–201. doi:10.1002/jaan.2014.26.issue-4
- Maher, R., Hanlon, J., & Hajjar, E. (2014). Clinical consequences of polypharmacy in elderly. Journal of Expert Opinion on Drug Safety, 13(1), 57–65. doi:10.1517/14740338.2013.827660
- McMillan, J., Aitken, E., & Holroyd-Leduc, J. (2013). Management of insomnia and long-term use of sedative-hypnotic drugs in older patients. Canadian Medical Association Journal, 185(17), 1499–1505. doi:10.1503/cmaj.130025
- Olazaran, J., Valle, D., Serra, J., Cano, P., & Muniz, R. (2013). Psychotropic medications and falls in nursing homes: A cross-sectional study. Journal of the American Medical Directors Association, 14, 213–217. doi:10.1016/j.jamda.2012.10.020
- Panula, J., Puustinen, J., Jaatinen, P., Vahlberg, T., Aarnio, P., & Kivela, S. (2009). Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture A retrospective, population based study. Drugs and Aging, 26(11), 963–971. doi:10.2165/11317660-000000000-00000
- Price, S., D’Arcy, C., Holman, J., Sanfilippo, F., & Emery, J. (2014). Impact of specific Beers criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: A case-time-control study in Western Australia. Drugs and Aging, 31, 311–325. doi:10.1007/s40266-014-0164-6
- Tannenbaum, C., Diaby, V., Singh, D., Perreault, S., Luc, M., & Vasiliadis, H. (2015). Sedative-hypnotic medicines and falls in community-dwelling older adults: A cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs and Aging, 32(4), 305–314. doi:10.1007/s40266-015-0251-3